Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Irhythm Technologies (0A7L) Share Price & Analysis

0A7L Stock Chart & Stats

$125.23-$2.48(-1.94%)
At close: 4:30 PM GMT
$110$120$1303 Aug17 Aug1 Sep14 Sep28 Sep12 Oct26 Oct
Day’s Range
$123.81 - $127.68
52-Week Range
$97.71 - $206.00
Previous Close
$127.71
Volume
16
Average Volume (3M)
64
Market Cap
$4.07B
Enterprise Value
$4.05B
Total Cash (Recent Filing)
$591.27M
Total Debt (Recent Filing)
$727.35M
Price to Earnings (P/E)
―
Beta
0.71
Next Earnings
Nov 05, 2026 (Est.)
EPS Estimate
0.01
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Sustained high-teens to low-20% revenue growth indicates expanding adoption of iRhythm’s monitoring platform and effective commercial execution. Raised annual guidance reinforces management’s confidence that demand can remain durable, supporting greater scale and operating leverage over the next several quarters.

Margin Expansion

Improving gross and adjusted EBITDA margins show that revenue growth is converting into stronger operating economics rather than requiring proportional expense growth. This progression can improve earnings quality, strengthen internal funding capacity, and support management’s longer-term margin targets.

Expanded Monitoring Platform

The completed VitalConnect acquisition expands iRhythm beyond its existing monitoring offering into additional ambulatory, inpatient, and hospital-to-home workflows. A broader product platform can increase addressable markets, deepen health-system relationships, and create more opportunities for cross-selling over time.

Bears Say

High Leverage

The debt-heavy capital structure reduces financial flexibility and leaves the company more exposed if operating performance weakens. Higher leverage can constrain investment choices, increase the importance of sustained cash generation, and make integration or product-development spending harder to absorb.

Inconsistent GAAP Profitability

Although EBITDA and adjusted earnings have improved, continued GAAP losses show that the business has not yet established consistently profitable operations. Persistent net losses can limit retained capital, reduce resilience during execution setbacks, and make the earnings improvement less proven over the medium term.

Regulatory Overhang

An unresolved FDA warning letter creates ongoing regulatory uncertainty around the company’s operating environment and management attention. Until the agency completes its review and closure is achieved, remediation requirements could delay priorities, increase compliance demands, or complicate expansion of the product roadmap.

Irhythm Technologies News

0A7L FAQ

What was Irhythm Technologies’s price range in the past 12 months?
Irhythm Technologies lowest share price was $97.71 and its highest was $206.00 in the past 12 months.
What is Irhythm Technologies’s market cap?
Irhythm Technologies’s market cap is $4.07B.
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s next earnings report is estimated for Nov 05, 2026 (not yet confirmed), which is in 3 days.
How were Irhythm Technologies’s earnings last quarter?
Irhythm Technologies released its earnings results on Aug 06, 2026. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.04 by $0.03.
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is 0.01.
How many shares outstanding does Irhythm Technologies have?
Irhythm Technologies has 32,963,000 shares outstanding.
What happened to Irhythm Technologies’s price movement after its last earnings report?
Irhythm Technologies reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.04. Following the earnings report the stock price went up 3.61%.
Which hedge fund is a major shareholder of Irhythm Technologies?
Hedge funds hold Irhythm Technologies shares: the largest hedge-fund position in Irhythm Technologies is 541,271,995 shares, and hedge funds decreased their holdings by 2.0M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology